Provention bio announces the grant of inducement awards

Red bank, n.j. , july 5, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company granted stock options to a new non-executive employee to purchase an aggregate of 7,000 shares of common stock.

PRVB Ratings Summary

PRVB Quant Ranking